John Crowley

2022

In 2022, John Crowley earned a total compensation of $1.4M as Chief Financial Officer at Fusion Pharmaceuticals, a 11% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$163,146
Option Awards$772,909
Salary$458,274
Other$48,684
Total$1,443,013

Crowley received $772.9K in option awards, accounting for 54% of the total pay in 2022.

Crowley also received $163.1K in non-equity incentive plan, $458.3K in salary and $48.7K in other compensation.

Rankings

In 2022, John Crowley's compensation ranked 2,300th out of 5,683 executives tracked by ExecPay. In other words, Crowley earned more than 59.5% of executives.

ClassificationRankingPercentile
All
2,300
out of 5,683
60th
Division
Manufacturing
1,247
out of 3,091
60th
Major group
Chemicals And Allied Products
555
out of 1,406
61st
Industry group
Drugs
510
out of 1,307
61st
Industry
Biological Products, Except Diagnostic Substances
125
out of 295
58th
Source: SEC filing on April 27, 2023.

Crowley's colleagues

We found two more compensation records of executives who worked with John Crowley at Fusion Pharmaceuticals in 2022.

2022

John Valliant

Fusion Pharmaceuticals

Chief Executive Officer

2022

Eric Burak

Fusion Pharmaceuticals

Chief Technology Officer

News

In-depth

You may also like